Activity ID
10632Expires
October 1, 2024Format Type
EnduringCME Credit
0.25Fee
$30CME Provider: American Medical Association
Description of CME Course
With the emergence of new treatments and technologies, physicians have a responsibility to ensure patients are well informed on their options. As part of the Informed Consent and Decision Making series, this Code of Medical Ethics module provides guidance to physicians regarding their responsibilities to communicate and maintain proper informed consent when it comes to innovative treatments, telemedicine, research, and genetic testing of children.
Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Orthopaedic Surgery
Pathology
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
1. Explain a physician's responsibilities for obtaining informed consent when using innovative treatments
2. Explain a physician's responsibilities for obtaining informed consent when practicing telemedicine
3. Explain a physician's responsibilities for obtaining informed consent when conducting research
4. Explain a physician's responsibilities for obtaining informed consent when conducting a genetic test on a child
Keywords
Ethics, Shared Decision Making and Communication
Competencies
Medical Knowledge, Professionalism
CME Credit Type
AMA PRA Category 1 Credit
DOI
10.1001/ama.2019.0280
